{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:46:23Z","timestamp":1777873583475,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2024ZD01004"],"award-info":[{"award-number":["2024ZD01004"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2413500"],"award-info":[{"award-number":["2023YFC2413500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejrad.2026.112705","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:08:31Z","timestamp":1769616511000},"page":"112705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prognostic value of functional MRI and liver function synergy in hepatocellular carcinoma patients receiving combined locoregional-systemic therapy: A multicenter scoring model"],"prefix":"10.1016","volume":"196","author":[{"given":"Langlang","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiqian","family":"Que","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfen","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3350-2210","authenticated-orcid":false,"given":"Zhuting","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejrad.2026.112705_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejrad.2026.112705_b0010","article-title":"Research progress of MRI-based radiomics in hepatocellular carcinoma","volume":"15","author":"Xie","year":"2025","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.ejrad.2026.112705_b0015","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11864-023-01098-9","article-title":"Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future prospects","volume":"24","author":"Alawyia","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"issue":"8","key":"10.1016\/j.ejrad.2026.112705_b0020","article-title":"METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy","volume":"4","author":"Pan","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ejrad.2026.112705_b0025","article-title":"The significance of Transarterial Chemo(Embolization) combined with Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: a Systematic Review","volume":"13","author":"Ke","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejrad.2026.112705_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1235724","article-title":"Hepatic arterial infusion chemotherapy plus lenvatinib with or without programmed cell death protein-1 inhibitors for advanced cholangiocarcinoma","volume":"14","author":"Wei","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ejrad.2026.112705_b0035","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/jmri.27143","article-title":"Predicting the Outcome of Transcatheter Arterial Embolization Therapy for Unresectable Hepatocellular Carcinoma based on Radiomics of Preoperative Multiparameter MRI","volume":"52","author":"Sun","year":"2020","journal-title":"J. Magn. Reson. Imaging"},{"issue":"10","key":"10.1016\/j.ejrad.2026.112705_b0040","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1007\/s00330-021-07910-0","article-title":"Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE","volume":"31","author":"Kong","year":"2021","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.112705_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2025.112296","article-title":"MRI imaging features for evaluating the efficacy and prognosis of TACE combined with targeted immunotherapy in unresectable hepatocellular carcinoma","volume":"191","author":"Yanfen","year":"2025","journal-title":"Eur. J. Radiol."},{"issue":"6","key":"10.1016\/j.ejrad.2026.112705_b0050","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.2214\/AJR.20.23213","article-title":"Hepatic Arterial infusion Chemotherapy for Advanced Hepatocellular Carcinoma: Radiologic and Clinical Factors Predictive of Survival","volume":"216","author":"Kim","year":"2021","journal-title":"AJR Am. J. Roentgenol."},{"issue":"7","key":"10.1016\/j.ejrad.2026.112705_b0055","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1007\/s00330-020-06675-2","article-title":"MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma","volume":"30","author":"Hectors","year":"2020","journal-title":"Eur. Radiol."},{"issue":"4","key":"10.1016\/j.ejrad.2026.112705_b0060","article-title":"Performance of an Easy and simple New Scoring Model in predicting Multidrug-Resistant Enterobacteriaceae in Community-acquired Urinary Tract Infections. Open Forum","volume":"6","author":"Ben Ayed","year":"2019","journal-title":"Infect. Dis."},{"issue":"11","key":"10.1016\/j.ejrad.2026.112705_b0065","first-page":"3867","article-title":"A multi-class scoring system based on CT features for preoperative prediction in gastric gastrointestinal stromal tumors","volume":"10","author":"Xu","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"3","key":"10.1016\/j.ejrad.2026.112705_b0070","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/jmri.27553","article-title":"Hepatocellular Carcinoma with Atypical Imaging Features: Review of the Morphologic Hepatocellular Carcinoma Subtypes with Radiology-Pathology Correlation","volume":"55","author":"Bello","year":"2022","journal-title":"J. Magn. Reson. Imaging"},{"issue":"3","key":"10.1016\/j.ejrad.2026.112705_b0075","doi-asserted-by":"crossref","DOI":"10.1148\/rg.240068","article-title":"Hepatobiliary and Pancreatic Neoplasms: Essential Predictive Imaging Features for Personalized Therapy","volume":"45","author":"Irizato","year":"2025","journal-title":"Radiographics"},{"issue":"2","key":"10.1016\/j.ejrad.2026.112705_b0080","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.230527","article-title":"Development of a Model including MRI Features for predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection","volume":"309","author":"Jiang","year":"2023","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.ejrad.2026.112705_b0085","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1007\/s00330-023-10279-x","article-title":"Prognostic MRI features to predict postresection survivals for very early to intermediate stage hepatocellular carcinoma","volume":"34","author":"Jiang","year":"2024","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.112705_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.964779","article-title":"Efficacy and safety of immune checkpoint inhibitors-combined antiangiogenic drugs in the treatment of hepatocellular carcinoma: a systematic review and meta analysis","volume":"12","author":"Zhong","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ejrad.2026.112705_b0095","first-page":"7","article-title":"Status and challenges of neoadjuvant immunotherapy for hepatocellular carcinoma","volume":"61","author":"Xia","year":"2023","journal-title":"Zhonghua Wai Ke Za Zhi"},{"issue":"2","key":"10.1016\/j.ejrad.2026.112705_b0100","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221835","article-title":"VICT2 Trait: Prognostic Alternative to Peritumoral Hepatobiliary phase Hypointensity in HCC","volume":"307","author":"Jiang","year":"2023","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.ejrad.2026.112705_b0105","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1093\/oncolo\/oyad329","article-title":"Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System with Integration of Imaging Features","volume":"29","author":"Tran Cao","year":"2024","journal-title":"Oncologist"},{"key":"10.1016\/j.ejrad.2026.112705_b0110","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231163845","article-title":"Development and validation of prognostic nomograms for large hepatocellular carcinoma after HAIC","volume":"15","author":"Yao","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"1","key":"10.1016\/j.ejrad.2026.112705_b0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00535-017-1348-8","article-title":"Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy","volume":"53","author":"Masuda","year":"2018","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.ejrad.2026.112705_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.mri.2024.110293","article-title":"P53 status combined with MRI findings for prognosis prediction of single hepatocellular carcinoma","volume":"116","author":"Huang","year":"2025","journal-title":"Magn. Reson. Imaging"},{"issue":"8","key":"10.1016\/j.ejrad.2026.112705_b0125","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.acra.2023.02.035","article-title":"A Reliable and Repeatable Model for predicting Microvascular Invasion in patients with Hepatocellular Carcinoma","volume":"30","author":"Tang","year":"2023","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.ejrad.2026.112705_b0130","article-title":"PD-1 combined with lenvatinib and TACE for the transformational treatment of hepatocellular carcinoma combined with portal vein tumor thrombus: a case report and literature review","volume":"13","author":"Liu","year":"2023","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.ejrad.2026.112705_b0135","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.4143\/crt.2022.1444","article-title":"Clinical significance of Combining Preoperative and Postoperative Albumin-Bilirubin score in Colorectal Cancer","volume":"55","author":"Kim","year":"2023","journal-title":"Cancer Res. Treat."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26000537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26000537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:03:54Z","timestamp":1777572234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X26000537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":27,"alternative-id":["S0720048X26000537"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.112705","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of functional MRI and liver function synergy in hepatocellular carcinoma patients receiving combined locoregional-systemic therapy: A multicenter scoring model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.112705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112705"}}